Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor (Q44228314)

1 December 2017

title

Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor (English)

1 reference

1 December 2017

1 reference

Hideki Mochida

1

1 reference

1 December 2017

Michino Takagi

2

1 reference

1 December 2017

Hirotaka Inoue

3

1 reference

1 December 2017

Tsunehisa Noto

4

1 reference

1 December 2017

Koji Yano

5

1 reference

1 December 2017

Kotomi Fujishige

6

1 reference

1 December 2017

Takashi Sasaki

7

1 reference

1 December 2017

Keizo Yuasa

8

1 reference

1 December 2017

Jun Kotera

9

1 reference

1 December 2017

Kenji Omori

10

1 reference

1 December 2017

Kohei Kikkawa

11

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

456

1 reference

1 December 2017

issue

1-3

1 reference

1 December 2017

page(s)

91-98

1 reference

Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Occurrence of the methylisobutylxanthine-stimulated cyclic GMP binding protein in various rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Guanosine 3':5'-cyclic monophosphate binding proteins in rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902590-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(02)02590-6

1 reference

1 December 2017

1 reference